Company Performance - Techne (TECH) reported quarterly earnings of $0.53 per share, exceeding the Zacks Consensus Estimate of $0.50 per share, and showing an increase from $0.49 per share a year ago, resulting in an earnings surprise of +6.00% [1] - The company achieved revenues of $316.96 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.48% and up from $306.1 million year-over-year [2] - Over the last four quarters, Techne has consistently surpassed consensus EPS and revenue estimates [2] Stock Outlook - Despite the positive earnings report, Techne shares have declined approximately 24.1% since the beginning of the year, contrasting with the S&P 500's gain of 7.1% [3] - The current consensus EPS estimate for the upcoming quarter is $0.44 on revenues of $295.53 million, and for the current fiscal year, it is $2.07 on revenues of $1.28 billion [7] Industry Context - The Medical - Biomedical and Genetics industry, to which Techne belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - The performance of Techne's stock may be influenced by the overall outlook of the industry, as research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by more than 2 to 1 [8]
Techne (TECH) Beats Q4 Earnings and Revenue Estimates